Alterations of the insulin-like growth factor system in patients with polycythemia vera

Molecular and Cellular Endocrinology

Volumn 181, Issue 1-2, 2001, Pages 189-197

  Michl, P ^a,c   Spoettl, G ^a   Engelhardt, D ^a   Weber, M M ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c UNIVERSITY OF ULM   (Germany)

Author keywords

IGF binding proteins; IGF I receptor; Polycythemia vera; Tyrosine kinase

Indexed keywords

RECEPTOR SUBUNIT; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; TYROSINE;

ADULT; AGE; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; FEMALE; GENE MUTATION; HUMAN; IMMUNOBLOTTING; MALE; MONONUCLEAR CELL; PATHOGENESIS; POLYCYTHEMIA VERA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; RADIOIMMUNOASSAY; RECEPTOR INTRINSIC ACTIVITY; SEX DIFFERENCE; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADULT; AGED; BLOTTING, WESTERN; EXONS; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PHOSPHORYLATION; PHOSPHOTYROSINE; POLYCYTHEMIA VERA; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RADIOIMMUNOASSAY; RECEPTOR, IGF TYPE 1;

EID: 0035811544     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(01)00489-0     Document Type: Article

References (35)

1. Therapeutic recommendations in polycythemia vera based on polycythemia vera study group protocols
2. Insulin-like growth factor binding protein (IGFBP) inhibits IGF action on human osteosarcoma cells
3. Insulin-like growth factor (IGF) binding protein-3 potentiation of IGF action is mediated through the phosphatidylinositol-3-kinase pathway and is associated with alteration in protein kinase B/AKT sensitivity
4. Production of erythropoietic bursts by progenitor cells from adult human peripheral blood in an improved serum-free medium: Role of insulinlike growth factor 1
5. Circulating erythroid progenitors in polycythemia vera are hypersensitive to insulin-like growth factor-1 in vitro: Studies in an improved serum-free medium
6. Polycythemia vera blood burst-forming units-erythroid are hypersensitive to interleukin-3
7. Differential effects of insulin-like growth factor (IGF)-binding protein-3 and its proteolytic fragments on ligand binding, cell surface association, and IGF-I receptor signaling
8. In polycythemia vera human interleukin -3 and granulocyte-macrophage colony-stimulating factor enhance erythroid colony growth in the absence of erythropoietin
9. Differential expression and biological effects of insulin-like growth factor-binding protein-4 and -5 in vascular smooth muscle cells
10. Insulin-like growth factor binding proteins: New proteins, new functions
11. The protein kinase family: Conserved features and deducted phylogeny of the catalytic domains
12. Overexpression of insulin-like growth factor-binding protein-2 results in increased tumorigenic potential in Y-1 adrenocortical tumor cells
13. Analysis of serum insulin-like growth factor binding protein using Western blotting: Use of the method for titration of the binding proteins and competitive binding studies
14. The insulin-like growth factor-binding protein superfamily
15. The effects of insulin-like growth factors on tumorigenesis and neoplastic growth
16. An altered IGF-I receptor is present in human leukemic cells
17. Insulin-like growth factor I stimulates erythropoiesis in hypophysectomized rats
18. Diagnosis and treatment of polycythemia vera and possible future study designs of the PVSG
19. Increased basal and induced tyrosine phosphorylation of the insulin-like growth factor I receptor β-subunit in circulating mononuclear cells of patients with polycythemia vera
20. Insulin-like growth factor binding protein-1 is elevated in patients with polycythemia vera and stimulates erythroid burst formation in vitro
21. Insulin-like growth factor I, ist binding proteins 1 and 3, and growth hormone-binding protein in children and adolescents with insulin-dependent diabetes mellitus: Clinical implications
22. IRS-1 is a common element in insulin and insulin-like growth factor-I signaling to the phosphatidylinositol 3'-kinase
23. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition
24. Towards a molecular understanding of polycythemia rubra vera
25. BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner
26. The insulin-like growth factor axis and growth in children with chronic renal failure: A report of the Southwest pediatric nephrology study group
27. Insulin-like growth factor-binding proteins in serum and other biological fluids: Regulation and functions
28. Intact but not truncated insulin-like growth factor binding protein-3 (IGFBP-3) blocks IGF-I-induced stimulation of osteoblasts: Control of IGF signalling to bone cells by IGFBP-3-specific proteolysis?
29. The sensitivity of single-strand conformation polymorphism analysis for the detection of single base substitutions
30. Insulin-like growth factor-I primary structure: Comparison with insulin receptor suggests structural determinants that define functional specifity
31. Insulin-like growth factor receptors in normal and tumorous adult human adrenocortical glands
32. Characterization of human insulin-like growth factor-binding proteins by two-dimensional polyacrylamide gel electrophoresis and western ligand blot analysis
33. Elevated serum levels of IGFBP-2 found in children suffering from acute leukaemia is accompanied by the occurrence of IGFBP-2 mRNA in the tumor clone
34. Growth factor receptor tyrosine kinases
35. Metabolic regulation of the growth hormone independent insulin-like growth factor binding protein in human plasma